Published in J Neurochem on May 01, 1978
The regulatory chain in the p36-kd substrate complex of viral tyrosine-specific protein kinases is related in sequence to the S-100 protein of glial cells. EMBO J (1985) 1.67
Immunoanatomic distribution of cytostructural and tissue-associated antigens in the human urinary tract. Am J Pathol (1987) 1.12
Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J Biol Chem (2000) 2.78
Immunochemical and immuno-cytochemical localization of S-100 antigen in normal human skin. Nature (1981) 1.87
S100B expression in and effects on microglia. Glia (2001) 1.28
S-100 proteins. Cell Calcium (1986) 1.17
Annexin V, annexin VI, S100A1 and S100B in developing and adult avian skeletal muscles. Neuroscience (2002) 1.02
S100B protects LAN-5 neuroblastoma cells against Abeta amyloid-induced neurotoxicity via RAGE engagement at low doses but increases Abeta amyloid neurotoxicity at high doses. J Neurosci Res (2006) 0.99
Free flaps in the treatment of locally advanced malignancy of the scalp and forehead. Ann Plast Surg (2002) 0.98
Nerve growth factor (NGF) influences differentiation and proliferation of myogenic cells in vitro via TrKA. Int J Dev Neurosci (2000) 0.97
S-100 protein, but not calmodulin, binds to the glial fibrillary acidic protein and inhibits its polymerization in a Ca(2+)-dependent manner. J Biol Chem (1993) 0.96
Nontuberculous mycobacteria in hospital water systems: application of HPLC for identification of environmental mycobacteria. J Water Health (2003) 0.96
Effects of S100A1 and S100B on microtubule stability. An in vitro study using triton-cytoskeletons from astrocyte and myoblast cell lines. Neuroscience (2000) 0.94
Role of the C-terminal extension in the interaction of S100A1 with GFAP, tubulin, the S100A1- and S100B-inhibitory peptide, TRTK-12, and a peptide derived from p53, and the S100A1 inhibitory effect on GFAP polymerization. Biochem Biophys Res Commun (1999) 0.94
Association of S100B with intermediate filaments and microtubules in glial cells. Biochim Biophys Acta (1998) 0.92
Calcified disease of the mitral annulus: a spectrum of an evolving disease. Ann Cardiol Angeiol (Paris) (2011) 0.90
Immunohistochemical localization of annexin V (CaBP33) in rat organs. J Histochem Cytochem (1991) 0.88
S-100 protein binds to annexin II and p11, the heavy and light chains of calpactin I. Biochim Biophys Acta (1992) 0.87
Soluble and membrane-bound S-100 protein in cerebral cortex synaptosomes. Properties of the S-100 receptor. Brain Res (1975) 0.87
S-100 (alpha and beta) binding peptide (TRTK-12) blocks S-100/GFAP interaction: identification of a putative S-100 target epitope within the head domain of GFAP. Biochim Biophys Acta (1996) 0.86
S-100a0 protein stimulates Ca2+-induced Ca2+ release from isolated sarcoplasmic reticulum vesicles. FEBS Lett (1989) 0.86
Annexin VI binds S100A1 and S100B and blocks the ability of S100A1 and S100B to inhibit desmin and GFAP assemblies into intermediate filaments. Cell Calcium (1998) 0.85
S100A1 and S100B interactions with annexins. Biochim Biophys Acta (2000) 0.84
Membrane-bound annexin V isoforms (CaBP33 and CaBP37) and annexin VI in bovine tissues behave like integral membrane proteins. FEBS Lett (1992) 0.84
Leukemia inhibitory factor enhances the regeneration of transected rat sciatic nerve and the function of reinnervated muscle. J Neurosci Res (1997) 0.83
Replicating myoblasts and fused myotubes express the calcium-regulated proteins S100A1 and S100B. Cell Calcium (1999) 0.83
Effects of calcium-binding proteins (S-100a(o), S-100a, S-100b) on desmin assembly in vitro. FASEB J (1996) 0.83
Annexin II2-p11(2) (calpactin I) stimulates the assembly of GFAP in a calcium- and pH-dependent manner. Biochem Biophys Res Commun (1995) 0.83
Immunocytochemical localization of S-100b protein in degenerating and regenerating rat sciatic nerves. J Histochem Cytochem (1989) 0.82
Annexin-immunoreactive proteins in the nervous system and eye of the gastropods, Aplysia and Helix. Brain Res (1997) 0.82
Mechanism of S100 protein-dependent inhibition of glial fibrillary acidic protein (GFAP) polymerization. Biochim Biophys Acta (1994) 0.82
S100B and S100A1 proteins in bovine retina:their calcium-dependent stimulation of a membrane-bound guanylate cyclase activity as investigated by ultracytochemistry. Neuroscience (1999) 0.82
Annexin V as a probe of the contribution of anionic phospholipids to the procoagulant activity of tumour cell surfaces. Blood Coagul Fibrinolysis (1994) 0.81
Prosaposin is immunolocalized to muscle and prosaptides promote myoblast fusion and attenuate loss of muscle mass after nerve injury. Muscle Nerve (2001) 0.81
Characterization of type III intermediate filament regulatory protein target epitopes: S-100 (beta and/or alpha) binds the N-terminal head domain; annexin II2-p11(2) binds the rod domain. Biochim Biophys Acta (1996) 0.81
Specific binding sites for S-100 protein in isolated brain nuclei. J Neurochem (1981) 0.81
Serum autoantibodies against glial fibrillary acidic protein in brain aging and senile dementias. Brain Behav Immun (1992) 0.79
Regulation of the p75 neurotrophin receptor in a rat myogenic cell line (L6). Histochem J (1999) 0.79
Immunocytochemical localization of annexin V (CaBP33), a Ca(2+)-dependent phospholipid- and membrane-binding protein, in the rat nervous system and skeletal muscles and in the porcine heart. J Cell Physiol (1992) 0.79
Characterization of mammalian heart annexins with special reference to CaBP33 (annexin V). FEBS Lett (1990) 0.79
The calcium-modulated proteins, S100A1 and S100B, as potential regulators of the dynamics of type III intermediate filaments. Braz J Med Biol Res (1999) 0.79
S100 calcium binding protein affects neuronal electrical discharge activity by modulation of potassium currents. Neuroscience (1999) 0.78
Time-resolved fluorescence of S-100a protein: effect of Ca2+, Mg2+ and unilamellar vesicles of egg phosphatidylcholine. Cell Calcium (1996) 0.78
S-100a0 protein stimulates the basal (Mg2+-activated) adenylate cyclase activity associated with skeletal muscle membranes. FEBS Lett (1989) 0.78
The specific interaction of S-100 protein with synaptosomal particulate fractions. Evidence for the formation of a tight complex between S-100 and its binding sites. J Neurochem (1981) 0.78
Effect of S-100 protein on assembly of brain microtubule proteins in vitro. FEBS Lett (1983) 0.78
Calcium-sensitivity of brain microtubule proteins in the presence of S-100 proteins. Cell Calcium (1985) 0.78
S-100 protein in cerebral cortex synaptosomes. Experientia (1974) 0.78
Chlorpromazine inhibits the calcium-mediated effects of S-100 protein(s) on assembled brain microtubule proteins, but not those on microtubule protein assembly. Biochem Biophys Res Commun (1984) 0.77
Mechanism of action of S-100 protein(s) on brain microtubule protein assembly. Biochem Biophys Res Commun (1984) 0.77
Solubilization and partial characterization of the S-100 protein binding activity of synaptosomal particulate fractions. J Neurochem (1977) 0.77
Immunocytochemical localization of annexins V and VI in human placentae of different gestational ages. Cell Mol Biol Res (1993) 0.77
An in vitro evaluation of the antibacterial activity of the non-volatile phenolic fraction from rosemary leaves. Nat Prod Res (2014) 0.77
Novel isoforms of CaBP 33/37 (annexin V) from mammalian brain: structural and phosphorylation differences that suggest distinct biological roles. Biochim Biophys Acta (1992) 0.77
Interaction of S-100b protein with cardiolipin vesicles as monitored by electron spin resonance, pyrene fluorescence and circular dichroism. Cell Calcium (1988) 0.77
Immunocytochemical analyses of annexin V (CaBP33) in a human-derived glioma cell line. Expression of annexin V depends on cellular growth state. FEBS Lett (1993) 0.76
'Neuron-specific' protein gene product 9.5 (PGP 9.5) is also expressed in glioma cell lines and its expression depends on cellular growth state. FEBS Lett (1991) 0.76
Soluble and membrane-bound S-100 protein in rat cerebral cortex synaptosomes during postnatal development. Brain Res (1976) 0.76
Detection of S-100b protein in Triton cytoskeletons: an immunocytochemical study on cultured Schwann cells. J Histochem Cytochem (1990) 0.76
Calpactin I binds to the glial fibrillary acidic protein (GFAP) and cosediments with glial filaments in a Ca(2+)-dependent manner: implications for concerted regulatory effects of calpactin I and S100 protein on glial filaments. Biochim Biophys Acta (1994) 0.76
Effects of S-100 proteins on assembly of brain microtubule proteins: correlation between kinetic and ultrastructural data. J Neurochem (1986) 0.76
Interaction of two brain annexins, CaBP33 and CaBP37, with membrane-skeleton proteins. FEBS Lett (1990) 0.76
Lifelong vaccination as a key disease-prevention strategy. Clin Microbiol Infect (2014) 0.75
Annexins V and VI in rat tissues during post-natal development: immunochemical measurements. Biochem Biophys Res Commun (1993) 0.75
S-100 protein-induced changes in the physical state of synaptosomal particulate fractions as monitored by spin labels. Arch Biochem Biophys (1985) 0.75
Identity between cytoplasmic and membrane-bound S-100 proteins purified from bovine and rat brain. J Neurochem (1986) 0.75
Binding of chlorpromazine to S-100 protein. J Neurochem (1984) 0.75
Counting the cost: estimating the economic benefit of pedophile treatment programs. Child Abuse Negl (2001) 0.75
Right ventricular obstructive hypertrophic cardiomyopathy in primary myo-adenylate deaminase deficiency. Acta Myol (2011) 0.75
Detection of membrane-bound guanylate cyclase activity in rat C6 glioma cells at different growth states following activation by natriuretic peptides. Brain Res (1995) 0.75
S-100 proteins and microtubules: analysis of the effects of rat brain S-100 (S-100b) and ox brain S-100a0, S-100a and S-100b on microtubule assembly-disassembly. FEBS Lett (1985) 0.75
A survey on tuberculin reactivity of medical students in the Universities of Florence and Pisa (Italy). Ann Ig (1994) 0.75
[Prevalence of antibodies against Coxiella burnetii in 2 geographical zones of Tuscany]. Ann Ig (1990) 0.75
Time-resolved fluorescence of S-100a protein in the absence and presence of calcium and phospholipids. Biochim Biophys Acta (1993) 0.75
Particulate guanylate cyclase and adenylate cyclase activities after activation with various agents in rabbit platelets. An ultracytochemical study. Histochem J (1991) 0.75
S-100b protein regulates aggregation and fusion of cardiolipin vesicles. Cell Calcium (1990) 0.75
Chemotaxis and chemical defenses in seaweed susceptibility to herbivory. Rev Bras Biol (2000) 0.75
Brain-specific effect of the S-100 protein on the RNA-polymerase I activity in isolated nuclei. Brain Res (1976) 0.75
Ultracytochemical localization of adenylate cyclase and guanylate cyclase in crushed peripheral nerves. Glia (1988) 0.75
S-100 protein and annexin II2-p11(2) (calpactin I) act in concert to regulate the state of assembly of GFAP intermediate filaments. Biochem Biophys Res Commun (1995) 0.75
Pyrazolo[1,5-a]pyrido[3,4-e]pyrimidin-6-ones. II. Synthesis and in vitro antimicrobial evaluation. Farmaco (1997) 0.75
Subnuclear distribution of the S-100 protein specific binding sites in rat brain. J Neurochem (1981) 0.75
Annexins in the gastropod nervous system. Acta Biol Hung (1995) 0.75
Further studies on the specific interaction of S-100 protein with synaptosomal particulates. J Neurochem (1976) 0.75
A food borne outbreak of Salmonella enterica serotype Brandenburg as a hint to compare human, animal and food isolates identified in the years 2005-2009 in Italy. J Prev Med Hyg (2011) 0.75
Heterogeneity of the S-100 protein specific binding sites in synaptosomal particulate fractions and subfractions. J Neurochem (1982) 0.75
Immunocytochemical localization of S-100 beta beta protein in olfactory and supporting cells of lamb olfactory epithelium. J Histochem Cytochem (1989) 0.75
Synthesis of 2-[1,2-dihydropyrazol-4-yl]-1,3,4-thiadiazole derivatives as potential antimicrobial agents. Farmaco (1990) 0.75
The specific interaction of S-100 protein with synaptosomal particulate fractions. Modulation of binding by fractional occupancy of sites and by the physical state of membranes. J Neurochem (1982) 0.75
[Evaluation of the Yersinia enterocolitica pathogenicity through some phenotypic and genotypic characters: CRMOX agar positivity and presence of the ail gene]. Ann Ig (2006) 0.75
Hospital acquired rota virus infection: the economics of prevention. Aust Health Rev (1993) 0.75
Biochemical and physicochemical properties of the solubilized S-100 protein binding activity of synaptosomal particulate fractions. Cell Mol Neurobiol (1983) 0.75
S-100b protein regulates the activity of skeletal muscle adenylate cyclase in vitro. FEBS Lett (1988) 0.75
Effect of NGF on the subcellular localization of group IIA secretory phospholipase A(2) (GIIA) in PC12 cells: role in neuritogenesis. Neurochem Res (2010) 0.75
Immunocytochemical localization of S-100 protein binding sites in synaptosomal fractions and subfractions. Cell Mol Neurobiol (1982) 0.75
Cardiac allograft vasculopathy : complications and imaging studies. Herz (2011) 0.75
[Effect of proteins S100 on RNA and protein biosynthesis in neurons and glial cells of the rat brain]. Biokhimiia (1983) 0.75
Membrane-bound guanylate cyclase as the receptor of natriuretic peptides. A minireview. Ital J Anat Embryol (1995) 0.75
Pyrazolo[1,5-a]pyrido[3,4-e]pyrimidin-6-ones. I. Synthesis and in vitro antimicrobial evaluation. Farmaco (1996) 0.75